Up
2006P-0288:
Permit an ANDA Suitability for Alprazolam
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| CP1
|
| 07/19/2006
|
| 07/19/2006
|
| Private Industry
|
| Beckloff Associates
|
|
|
|
|
|
|
| pdf
Tab
1, Tab
2
|
|
|
|
| Signature:
|
| Michael C. Beckloff
|
|
|
| ACK1
|
| 07/19/2006
|
| 07/19/2006
|
| Federal Government
|
| FDA/ DDM to Beckloff
Associates
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Gloria Ortega
|
|
Top | Up
Page last updated
August 11, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |